Asthmatic changes in mice lacking T-bet are mediated by IL-13

International Immunology

Volumn 17, Issue 8, 2005, Pages 993-1007

  Finotto, Susetta ^a   Hausding, Michael ^a   Doganci, Aysefa ^a   Maxeiner, Joachim H ^a   Lehr, Hans A ^a   Luft, Cornelia ^a   Galle, Peter R ^a   Glimcher, Laurie H ^b,c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Airway remodeling; Asthma; Cytokines; T bet; TGF

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD4 ANTIGEN; CD69 ANTIGEN; HERMES ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; ASTHMA; BODY PLETHYSMOGRAPHY; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LUNG FIBROBLAST; LUNG RESISTANCE; MEMORY CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; WESTERN BLOTTING;

ACTINS; ANIMALS; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DNA-BINDING PROTEINS; FIBROBLASTS; IMMUNOLOGIC MEMORY; INTERLEUKIN-13; INTERLEUKIN-4; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SMAD3 PROTEIN; SMAD7 PROTEIN; T-BOX DOMAIN PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

EID: 23844473010     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh281     Document Type: Article

References (62)

1. Cohn, L., Elias, J. A. and Chupp, G. L. 2004. Asthma: Mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22:789.
2. Gavett, S. H., O'Hearn, D. J., Li, X., Huang, S. K., Finkelman, F. D. and Wills-Karp, M. 1995. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182:1527.
3. Szabo, S. J., Sullivan, B. M., Stemmann, C., Satoskar, A. R., Sleckman, B. P. and Glimcher, L. H. 2002. Distinct effects of T-bet in Th1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295:338.
4. Szabo, S. J., Sullivan, B. M., Peng, S. L. and Glimcher, L. H. 2003. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21:713.
5. Finotto, S., Neurath, M. F., Glickman, J. N. et al. 2002. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295:336.
6. Finotto, S. and Glimcher, L. H. 2004. T cell directives for transcriptional regulation in asthma. Springer Semin. Immunopathol. 25:281.
7. Simmons, J. G., Pucilowska, J. B., Keku, T. O. and Lund, P. K. 2002. IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am. J. Physiol. Gastrointest. Liver Physiol. 283:G809.
8. Richter, A., Puddicombe, S. M., Lordan, J. L. et al. 2001. The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. Am. J. Respir. Cell Mol. Biol. 25:385.
9. Doucet, C., Brouty-Boye, D., Pottin-Clemenceau, C., Canonica, G.W., Jasmin, C. and Azzarone, B. 1998. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J. Clin. Invest. 101:2129.
10. Zhu, Z., Enhorning, G., Zheng, T. et al. 2003. Interleukin-13 induces surfactant function abnormality in the murine lung. Chest 123:375S.
11. Zhu, Z., Zheng, T., Homer, R. J. et al. 2004. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 304:1678.
12. Lee, C. G., Homer, R. J., Zhu, Z. et al. 2001. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β. J. Exp. Med. 194:809.
13. Robinson, D. S. and Lloyd, C. M. 2002. Asthma: T-bet- a master controller? Curr. Biol. 12:R322.
14. Finotto, S., De Sanctis, G. T., Lehr, H. A. et al. 2001. Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of gata-3 expression. J. Exp. Med. 193:1247.
15. Packham, E. A. and Brook, J. D. 2003. T-box genes in human disorders. Hum. Mol. Genet. 12(Spec. no. 1):R37.
16. Gorelik, L., Constant, S. and Flavell, R. A. 2002. Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 195:1499.
17. Howard, T. D., Whittaker, P. A., Zaiman, A. L. et al. 2001. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am. J. Respir. Cell Mol. Biol. 25:377.
18. Finotto, S., Buerke, M., Lingnau, K., Schmitt, E., Galle, P. R. and Neurath, M. F. 2001. Local administration of antisense phosphorothioate oligonucleotides to the c-kit ligand, stem cell factor, suppresses airway inflammation and IL-4 production in a murine model of asthma. J. Allergy Clin. Immunol. 107:279.
19. Akbari, O., Stock, P., DeKruyff, R. H. and Umetsu, D. T. 2003. Role of regulatory T cells in allergy and asthma. Curr. Opin. Immunol. 15:627.
20. Neurath, M. F., Weigmann, B., Finotto, S. et al. 2002. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195:1129.
21. Stassen, M., Jonuleit, H., Muller, C. et al. 2004. Differential regulatory capacity of CD25+ T regulatory cells and preactivated CD25+ T regulatory cells on development, functional activation, and proliferation of Th2 cells. J. Immunol. 173:267.
22. Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, G. C. and Glimcher, L. H. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655.
23. Avni, O., Lee, D., Macian, F., Szabo, S. J., Glimcher, L. H. and Rao, A. 2002. Th cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat. Immunol. 3:643.
24. Mullen, A. C., Hutchins, A. S., High, F. A. et al. 2002. Hlx is induced by and genetically interacts with T-bet to promote heritable Th1 gene induction. Nat. Immunol. 10:652.
25. Afkarian, M., Sedy, J. R., Yang, J. et al. 2002. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat. Immunol. 3:549.
26. Lighvani, A. A., Frucht, D. M., Jankovic, D. et al. 2001. T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells. Proc. Natl Acad. Sci. USA 98:15137.
27. Mullen, A. C., High, F. A., Hutchins, A. S. et al. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292:1907.
28. Ohno, I., Nitta, Y., Yamauchi, K. et al. 1996. Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. Am. J. Respir. Cell Mol. Biol. 15:404.
29. Minshall, E. M., Leung, D. Y., Martin, R. J. et al. 1997. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 17:326.
30. Khalil, N., Parekh, T. V., O'Connor, R. et al. 2001. Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis. Thorax 56:907.
31. Martin, M., Lefaix, J. and Delanian, S. 2000. TGF-beta1 and radiation fibrosis: A master switch and a specific therapeutic target? Int. J. Radiat. Oncol. Biol. Phys. 47:277.
32. Roberts, A. B., Piek, E., Bottinger, E. P., Ashcroft, G., Mitchell, J. B. and Flanders, K. C. 2001. Is SMAD3 a major player in signal transduction pathways leading to fibrogenesis? Chest 120:43S.
33. Huaux, F., Liu, T., McGarry, B., Ullenbruch, M. and Phan, S. H. 2003. Dual roles of IL-4 in lung injury and fibrosis. J. Immunol. 170:2083.
34. Kolodsick, J. E., Toews, G. B., Jakubzick, C. et al. 2004. Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts. J. Immunol. 172:4068.
35. Kodera, T., McGaha, T. L., Phelps, R., Paul, W. E. and Bona, C. A. 2002. Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-beta production by fibroblasts. Proc. Natl Acad. Sci. USA 99:3800.
36. Akbari, O., Stock, P., Meyer, E. et al. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9:582.
37. Townsend, M., Weinmann, A. S., Matsuda, J. et al. 2004. T-bet regulates the terminal maturation and homeostasis of NK and Val4iNKT cells. Immunity 20:477.
38. Wills-Karp, M., Luyimbazi, J., Xu, X. et al. 1998. Interleukin-13: central mediator of allergic asthma. Science 282:2258.
39. Walter, D. M., McIntire, J. J., Berry, G. et al. 2001. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J. Immunol. 167:4668.
40. Mattes, J., Yang, M., Mahalingam, S. et al. 2002. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J. Exp. Med. 195:1433.
41. Kuperman, D. A., Huang, X., Koth, L. L. et al. 2002. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 8:885.
42. Wills-Karp, M. 2000. The gene encoding interleukin-13: A susceptibility locus for asthma and related traits. Respir. Res. 1:19.
43. Wills-Karp, M. 2001. IL-12/IL-13 axis in allergic asthma. J. Allergy Clin. Immunol. 107:9.
44. Zhu, Z., Homer, R. J., Wang, Z. et al. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103:779.
45. Wenzel, S. E., Trudeau, J. B., Barnes, S. et al. 2002. TGF-beta and IL-13 synergistically increase eotaxin-1 production in human airway fibroblasts. J. Immunol. 169:4613.
46. Foster, P. S., Martinez-Moczygemba, M., Huston, D. P. and Corry, D. B. 2002. Interleukins-4, -5, and -13: Emerging therapeutic targets in allergic disease. Pharmacol. Ther. 94:253.
47. Kumar, R. K., Herbert, C., Yang, M., Koskinen, A. M., McKenzie, A. N. and Foster, P. S. 2002. Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma. Clin. Exp. Allergy 32:1104.
48. Schmid-Grendelmeier, P., Altznauer, F., Fischer, B. et al. 2002. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J. Immunol. 169:1021.
49. Grunig, G., Ford, J. G., Donaldson, D. D. et al. 2002. Roles of interleukin-13 and interferon-gamma in lung inflammation. Chest 121:88S.
50. Mattes, J., Yang, M., Siqueira, A. et al. 2001. IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung. J. Immunol. 167:1683.
51. Zheng, T., Zhu, Z., Liu, W. et al. 2003. Cytokine regulation of IL-13Ralpha2 and IL-13Ralpha1 in vivo and in vitro. J. Allergy Clin. Immunol. 111:720.
52. Taube, C., Duez, C., Cui, Z. H. et al. 2002. The role of IL-13 in established allergic airway disease. J. Immunol. 169:6482.
53. Wood, N., Whitters, M. J., Jacobson, B. A. et al. 2003. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J. Exp. Med. 197:703.
54. McKenzie, A. N. and Fallon, P. G. 2003. Decoy receptors in the regulation of T helper cell type 2 responses. J. Exp. Med. 197:675.
55. Funaba, M. and Mathews, L. S. 2000. Identification and characterization of constitutively active Smad2 mutants: Evaluation of formation of Smad complex and subcellular distribution. Mol. Endocrinol. 14:1583.
56. Souchelnytskyi, S., Tamaki, K., Engstrom, U., Wernstedt, C., ten Dijke, P. and Heldin, C. H. 1997. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling. J. Biol. Chem. 272:28107.
57. Kretzschmar, M., Doody, J., Timokhina, I. and Massague, J. 1999. A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. Genes Dev. 13:804.
58. Piek, E., Ju, W. J., Heyer, J. et al. 2001. Functional characterization of transforming growth factor beta signaling in Smad2- and SMAD3-deficient fibroblasts. J. Biol. Chem. 276:19945.
59. Lakos, G., Takagawa, S., Chen, S. J. et al. 2004. Targeted disruption of TGF-beta/SMAD3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am. J. Pathol. 165:203.
60. Flanders, K. C., Major, C. D., Arabshahi, A. et al. 2003. Interference with transforming growth factor-beta/ SMAD3 signaling results in accelerated healing of wounds in previously irradiated skin. Am. J. Pathol. 163:2247.
61. Tantisira, K. G., Hwang, E. S., Raby, B. A. et al. 2004. TBX21: A functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc. Natl Acad. Sci. USA 101: 18099.
62. Silverman, E. S., Palmer, L. J., Subramaniam, V. et al. 2004. Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. Am. J. Respir. Crit. Care Med. 169:214.